-
Horizon Pharma's Topline Phase 3 ACTIMMUNE Results Didn't Meet Primary, Secondary Endpoint
Thursday, December 8, 2016 - 8:53am | 384Horizon Pharma PLC (NASDAQ: HZNP), a biopharmaceutical company that focuses on unmet medical needs, announced Thursday topline results from a Phase 3 study called STEADFAST. The trial evaluated Horizon's ACTIMMUNE therapy for the treatment of of Friedreich's ataxia, a rare inherited...
-
Horizon Pharma Reverses Earlier Gains Following Patent Litigation Settlement
Thursday, May 12, 2016 - 10:23am | 131Shares of Horizon Pharma PLC (NASDAQ: HZNP) were trading higher by more than 3 percent ahead of Thursday's market open. However, after 30 minutes of trading the stock was trading lower for the day by nearly 2 percent. The company announced earlier in the morning its affiliates have entered...
-
This Explains Horizon Pharma's 25% Plunge
Tuesday, April 12, 2016 - 2:00pm | 127Shares of Horizon Pharma PLC (NASDAQ: HZNP) plunged more than 25 percent on Tuesday after the company released an investor presentation which included revenue outlook. Horizon Pharma said it expects its 2016 revenue to be in a range of $1.025 billion to $1.05 billion and adjusted EBITDA to be...
-
Stifel Reiterates Horizon Pharma As 'Select List' Pick, Sees 'Buying Opportunity In Multiple Misguided Reactions'
Wednesday, September 23, 2015 - 8:50am | 449Shares of Horizon Pharma PLC (NASDAQ: HZNP) have come under "inordinate pressure" in the last few days, according to Annabel Samimy of Stifel. Samimy maintained a Buy rating and $45 price target on the stock. According to Samimy, Horizon is "one of the stronger diversified...
-
Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties
Tuesday, July 29, 2014 - 4:37pm | 2823U.S. stocks fell as the Dow dipped below the 17,000 marks as geopolitical concerns become a main focus. In a televised statement, President Obama said the United States will expand on sanctions meant to hurt Russia's energy, defense and financial sectors. The move follows Russia's...
-
Markets Little Changed Ahead Of The Federal Reserve's Policy Decision
Monday, July 28, 2014 - 4:36pm | 2462U.S. stocks were little changed ahead of the Federal Reserve's policy announcement due out on Wednesday. The Federal Reserve will conclude a two-day session, with the central bank likely to announce further cuts to its monthly asset purchases. In economic news, June home sales declined in...
-
Market Wrap For March 19: Yellen Hints of Higher Rates & Sooner Than Expected End To Taper
Wednesday, March 19, 2014 - 6:03pm | 2470The Fed announced that it will increase its tapering by a further $10 billion in addition to dropping the 6.5 percent unemployment rate threshold which has been the target rate to hike the Fund Funds rate. Thirteen of 16 Fed officials expect the Fed Funds rate to rise by the end of 2015. The...
-
Top Trending Tickers On StockTwits For March 19
Wednesday, March 19, 2014 - 10:52am | 640Here's a look at the top tickers trending on StockTwits.com. FedEx: Earnings miss This morning, FedEx (NYSE: FDX) reported its third quarter results. The company announced an EPS of $1.23, missing the consensus estimate of $1.46. Revenue of $11.3 billion missed the consensus estimate of $11.46...